|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
M
MacArthur, Judy, 1989, Vol. 03(1) pp. 5
MacDonald, Hope, 1990, Vol. 04(3) pp. 4
Mack, Judith E., 1990, Vol. 04(3) pp. 1
MacMillan, Donald, 1998, Vol. 12(1) pp. 2; 1998, Vol. 12(3) pp. 7.
macrocephaly, 1997, Vol. 11(1) pp. 4
macrographia, 2001, Vol. 15(3) pp. 5
macrogyria, 1990, Vol. 04(3) pp. 4
mad cow disease, 1999, Vol. 13(2) pp. 3
Mad Log, 1996, Vol. 10(1) pp. 7
Madsen, Kreesten Meldgaard, 2004, Vol. 18(3) pp. 1
magnesium
and 5-HTP for sleep and behavior, 1999, Vol. 13(1) pp. 2
for ADHD, 2001, Vol. 15(2) pp. 6
for aggression, 1992, Vol. 06(2) pp. 6; 1992, Vol. 06(4) pp. 6; 1996, Vol. 10(4) pp. 7; 2001, Vol. 15(1) pp. 6; 2001, Vol. 15(4) pp. 3.
for alertness, 1996, Vol. 10(3) pp. 7
for attention, 1994, Vol. 08(3) pp. 6; 1994, Vol. 08(4) pp. 7; 2001, Vol. 15(2) pp. 6.
for behavior, 1991, Vol. 05(2) pp. 7; 1998, Vol. 12(2) pp. 7.
for cerebral palsy, 1995, Vol. 09(1) pp. 4
for cerebral palsy prevention in utero, 1995, Vol. 09(1) pp. 4
for communication, 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(1) pp. 7; 1994, Vol. 08(2) pp. 6.
for comprehension, 1998, Vol. 12(2) pp. 7; 1998, Vol. 12(3) pp. 7.
dosages, 1997, Vol. 11(4) pp. 3
and drugs, 1992, Vol. 06(2) pp. 2; 1996, Vol. 10(3) pp. 2.
and early intervention, 1998, Vol. 12(1) pp. 2
for fixations, 1991, Vol. 05(4) pp. 7
for focus, 1996, Vol. 10(3) pp. 7; 2001, Vol. 15(2) pp. 6.
for Fragile X, 1993, Vol. 07(2) pp. 4
for functional association, 1990, Vol. 04(2) pp. 4
for hyperactivity, 1998, Vol. 12(2) pp. 4
for hypersensitive hearing, 1992, Vol. 06(4) pp. 6; 1998, Vol. 12(3) pp. 7.
for insomnia, 1994, Vol. 08(3) pp. 2
for language disorders, 1990, Vol. 04(4) pp. 7; 1995, Vol. 09(2) pp. 7.
for mood, 1991, Vol. 05(2) pp. 7
for panic attacks, 2001, Vol. 15(1) pp. 6
for peripheral neuropathy, 1996, Vol. 10(3) pp. 3
scientific proof of its effectiveness, 1999, Vol. 13(3) pp. 3
for seizures, 1995, Vol. 09(4) pp. 3
for self-injury, 1992, Vol. 06(2) pp. 6
for self-stimulating behaviors, 1996, Vol. 10(3) pp. 7
for sleep, 1991, Vol. 05(2) pp. 7; 1994, Vol. 08(2) pp. 6.
for sociability, 1993, Vol. 07(1) pp. 7
for sound sensitivity, 1990, Vol. 04(4) pp. 3; 1991, Vol. 05(1) pp. 3; 1991, Vol. 05(3) pp. 2; 1994, Vol. 08(1) pp. 7; 1998, Vol. 12(3) pp. 7.
for speech, 1994, Vol. 08(1) pp. 7; 1994, Vol. 08(2) pp. 6; 1996, Vol. 10(3) pp. 7; 1998, Vol. 12(1) pp. 7; 1998, Vol. 12(3) pp. 7; 2001, Vol. 15(3) pp. 6.
Super Nu-Thera (Kirkman Labs), 1993, Vol. 07(3) pp. 6
for tantrums, 1994, Vol. 08(3) pp. 2
for tinnitus, 1998, Vol. 12(3) pp. 7
magnetic resonance imaging. See MRI
Mahaffey, Kathryn
Mahendran, R., 2003, Vol. 17(1) pp. 6
Maino, Dominick M., 1991, Vol. 05(4) pp. 4
mainstreaming, 1992, Vol. 06(4) pp. 1; 1993, Vol. 07(1) pp. 1; 1993, Vol. 07(2) pp. 6; 1993, Vol. 07(3) pp. 6; 1998, Vol. 12(1) pp. 5. See also inclusion
major histocompatibility complex (MHC), 1996, Vol. 10(4) pp. 2
Making Contact: Sensory Integration and Autism (Reisman and King), 1995, Vol. 09(1) pp. 6
malabsorption. See food intolerances
Malone, R. P., 2002, Vol. 16(1) pp. 5
Maloney, Carolyn (Rep., N.Y.), 2004, Vol. 18(2) pp. 6
Maloney, Michael J., 1996, Vol. 10(1) pp. 7
malvin, 1995, Vol. 09(4) pp. 6
Mandel, Jean-Louis, 1991, Vol. 05(2) pp. 12
Mandell, Arnold, 1997, Vol. 11(2) pp. 3
Mandell, Marshall, 1989, Vol. 03(2) pp. 3
mania, 1989, Vol. 03(3) pp. 4; 1998, Vol. 12(2) pp. 3.
manic depression. See bipolar disorder
Manjiviona, Janine, 1995, Vol. 09(2) pp. 6
Mankoski, Raymond, 2000, Vol. 14(3) pp. 7
mannerisms, 1989, Vol. 03(4) pp. 2; 1997, Vol. 11(3) pp. 1. See also behaviors
Manning, John T., 2001, Vol. 15(2) pp. 5
Mapstone, Eileen, 1998, Vol. 12(1) pp. 5
March, John, 2002, Vol. 16(1) pp. 6
Marfan's syndrome, 1991, Vol. 05(1) pp. 4
Margolese, H. C., 2002, Vol. 16(4) pp. 7
marijuana, 2002, Vol. 16(3) pp. 7
for anxiety, 2002, Vol. 16(2) pp. 7
Marinol and "smoked dope" compared, 2003, Vol. 17(2) pp. 6; 2003, Vol. 17(3) pp. 6.
and seizures, 2003, Vol. 17(4) pp. 4
side effects from, 2003, Vol. 17(1) pp. 3
for Tourette's, 1998, Vol. 12(2) pp. 7
website, 2003, Vol. 17(1) pp. 34
Mariner, Robin, 1987, Vol. 01(2) pp. 4
Marinol
Markowitz, P. I.
Marone, Frank
Marquez, Gayle, 1991, Vol. 05(1) pp. 7
Marriage, Keith J., 1995, Vol. 09(2) pp. 6
Marshall University's Autism Training Center, 2004, Vol. 18(1) pp. 5
Marsicano, Giovanni, 2003, Vol. 17(4) pp. 4
Martin, A., 2004, Vol. 18(2) pp. 2
Martin, Andrιs, 1999, Vol. 13(4) pp. 4
Martin-Bell Syndrome. See Fragile X
Martineau, J., 1988, Vol. 02(4) pp. 2; 1990, Vol. 04(2) pp. 4.
Maryland, 2004, Vol. 18(4) pp. 3
Maryland Special Education, 1999, Vol. 13(4) pp. 2
Masi, G., 2001, Vol. 15(4) pp. 5
Masnik, Debbie, 1994, Vol. 08(4) pp. 2
Mason, Susan Ann, 1990, Vol. 04(4) pp. 5; 1991, Vol. 05(1) pp. 5; 1991, Vol. 05(2) pp. 3; 1995, Vol. 09(2) pp. 5.
Massachusetts, 2004, Vol. 18(4) pp. 3
Massachusetts Department of Mental Retardation, 1995, Vol. 09(4) pp. 2; 1997, Vol. 11(3) pp. 5.
massage therapy, 2002, Vol. 16(1) pp. 5
Massaro, Dominic W., 2001, Vol. 15(4) pp. 5
Massie, Henry, 1987, Vol. 01(3) pp. 3
Masters, Roger D., 1998, Vol. 12(4) pp. 5
maternal age, 2002, Vol. 16(4) pp. 2
maternal antibodies, 2003, Vol. 17(1) pp. 6
maternal immune response, 2003, Vol. 17(2) pp. 2
Mates, Thomas, 1991, Vol. 05(3) pp. 6
mathematics and music, link in abilities, 1989, Vol. 03(1) pp. 2
Matson, J. L., 1988, Vol. 02(3) pp. 1, 3, 8
Maurer, Ralph, 1991, Vol. 05(4) pp. 3
Maurice, Catherine, 1994, Vol. 08(1) pp. 3; 1994, Vol. 08(3) pp. 3; 1995, Vol. 09(1) pp. 5.
Maydell, Bernhard, 2002, Vol. 16(2) pp. 5
Mayes, Frances, 2002, Vol. 16(3) pp. 7
Mayo, Duffy, 1988, Vol. 02(2) pp. 3; 1988, Vol. 02(4) pp. 6.
MBP (myelin basic protein), 1993, Vol. 07(1) pp. 5; 2000, Vol. 14(4) pp. 1.
McBridge, P. Anne, 1996, Vol. 10(4) pp. 5
McCandless, Jaquelyn, 2002, Vol. 16(1) pp. 9; 2002, Vol. 16(2) pp. 3.
McCarthy, P., 1989, Vol. 03(2) pp. 1
McClannahan, Lynn E., 1992, Vol. 06(2) pp. 5; 1993, Vol. 07(1) pp. 1; 1998, Vol. 12(3) pp. 5.
McClelland, Mark (FDA Commissioner), 2003, Vol. 17(2) pp. 1
McClelland, R. J., 1992, Vol. 06(4) pp. 1
McConnaughey, Janet, 1999, Vol. 13(4) pp. 7
McConnell, Mitch (U.S. Senator), 2004, Vol. 18(4) pp. 3
McConville, B. J., 1998, Vol. 12(2) pp. 7
McCormick, Marie, 2001, Vol. 15(3) pp. 1
McCown, Thomas, 2003, Vol. 17(3) pp. 4
McCracken, James T., 2002, Vol. 16(4) pp. 6
McCully, Kilmer, 1996, Vol. 10(3) pp. 3; 1997, Vol. 11(3) pp. 3.
McDonnel, Jane, 1993, Vol. 07(3) pp. 1
McDonnell, Maureen, 1998, Vol. 12(4) pp. 1
McDonough, M., 2001, Vol. 15(1) pp. 4
McDougle, Christopher J., 1993, Vol. 07(4) pp. 1
on clonipramine, 1992, Vol. 06(4) pp. 5; 1993, Vol. 07(3) pp. 1.
on fluvoxamine, 1991, Vol. 05(1) pp. 4; 1995, Vol. 09(4) pp. 1; 1996, Vol. 10(4) pp. 7.
on risperidone, 1996, Vol. 10(2) pp. 2; 1998, Vol. 12(3) pp. 1.
on sertraline, 1998, Vol. 12(2) pp. 4
on tryptophan depletion, 1993, Vol. 07(3) pp. 2
McEachin, John, 1988, Vol. 02(3) pp. 2; 1993, Vol. 07(1) pp. 1; 1995, Vol. 09(3) pp. 5.
McEvoy, John, 1990, Vol. 04(1) pp. 5
McGee, John J., 1989, Vol. 03(3) pp. 1; 1995, Vol. 09(1) pp. 6.
McGillivray, Barbara, 1987, Vol. 01(1) pp. 7
McGimsey, James, 1988, Vol. 02(4) pp. 6; 1989, Vol. 03(1) pp. 1.
McGinnis, Woody, 2002, Vol. 16(3) pp. 1; 2003, Vol. 17(3) pp. 3.
McHale, Susan, 1991, Vol. 05(3) pp. 6
McKelvey, J. Roger, 1995, Vol. 09(4) pp. 5
McLure, Norman and Sandra, 1994, Vol. 08(1) pp. 7
McMaster, Scott, 1987, Vol. 01(3) pp. 2
McMorrow, M. J., 1987, Vol. 01(3) pp. 5
McNulty, Carol A., 1993, Vol. 07(4) pp. 6
McPartland, James, 2004, Vol. 18(3) pp. 7
MDMA, 1988, Vol. 02(4) pp. 2; 1989, Vol. 03(1) pp. 4.
Me Book (Lovaas), 1994, Vol. 08(1) pp. 3
measles
antibodies of, 1999, Vol. 13(1) pp. 4; 2001, Vol. 15(4) pp. 7; 2002, Vol. 16(1) pp. 6; 2003, Vol. 17(2) pp. 6.
and autism, 2000, Vol. 14(2) pp. 7
cattle version of, 2002, Vol. 16(1) pp. 6
and inflammatory bowel disease, 2000, Vol. 14(2) pp. 7; 2002, Vol. 16(1) pp. 1; 2002, Vol. 16(2) pp. 1; 2004, Vol. 18(2) pp. 1.
vaccine strain of, 2002, Vol. 16(3) pp. 1
and vitamin A, 2000, Vol. 14(1) pp. 5
measles-mumps-rubella (MMR) vaccine
autism link, 1995, Vol. 09(2) pp. 7; 2001, Vol. 15(1) pp. 2; 2002, Vol. 16(1) pp. 1; 2002, Vol. 16(3) pp. 1; 2004, Vol. 18(2) pp. 1.
and autoimmune diseases, 2000, Vol. 14(1) pp. 3; 2000, Vol. 14(4) pp. 1.
and behaviors, 1998, Vol. 12(1) pp. 1
cattle version withdrawn, 2002, Vol. 16(1) pp. 6
Center for Disease Control study and, 2000, Vol. 14(2) pp. 2
Danish study on autism link, 2003, Vol. 17(3) pp. 3; 2004, Vol. 18(3) pp. 1.
and DTwcP (diptheria-tetanus-and-whole-cell-pertussis) vaccine compared, 2003, Vol. 17(2) pp. 1
and gastrointestinal symptoms, 1998, Vol. 12(1) pp. 1
general discussion, 1995, Vol. 09(1) pp. 1
heavy metal toxicity and adverse reactions to, 2002, Vol. 16(3) pp. 2
and inflammatory bowel disease, 1996, Vol. 10(4) pp. 1; 1998, Vol. 12(1) pp. 6; 2000, Vol. 14(2) pp. 7; 2001, Vol. 15(1) pp. 1; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(2) pp. 1.
Institute of Medicine's position on, 2001, Vol. 15(3) pp. 1
lawsuits, 1999, Vol. 13(2) pp. 3
licensing of, 2000, Vol. 14(4) pp. 1
measles titer for, 2001, Vol. 15(4) pp. 7
safety risks of, 2001, Vol. 15(2) pp. 3; 2001, Vol. 15(3) pp. 2; 2001, Vol. 15(4) pp. 1.
mecamylamine, 1998, Vol. 12(4) pp. 2
meconium staining, 2004, Vol. 18(1) pp. 6
MeCP2
Medco, 2004, Vol. 18(2) pp. 4
media content, 2003, Vol. 17(3) pp. 3
medical food, 2003, Vol. 17(3) pp. 6
medical insurance. See health, insurance
Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, 2000, Vol. 14(2) pp. 1; 2002, Vol. 16(3) pp. 1; 2003, Vol. 17(3) pp. 2.
Medical Mavericks (Riordan, Hugh), 1989, Vol. 03(4) pp. 3
Medical Treatment for Down Syndrome (Turkel), 1992, Vol. 06(3) pp. 2
Medical University of South Carolina, 1989, Vol. 03(4) pp. 1
MedicAlert bracelets, 1994, Vol. 08(1) pp. 1
medications. See drugs. See drug interactions and individual drug entries
Medicines and Healthcare Products Regulatory Authority (MHRA) in U.K., 2003, Vol. 17(3) pp. 2
Medigenesis database, 2001, Vol. 15(1) pp. 3
meditation, 2003, Vol. 17(3) pp. 7
medium-chain triglyceride (MCT) diet, 1988, Vol. 02(2) pp. 4
megacolon, 2003, Vol. 17(1) pp. 6
megalencephaly, 1994, Vol. 08(1) pp. 4
megarectum, 2003, Vol. 17(4) pp. 5
megavitamin therapy. See supplements
Megson, Mary A., 2000, Vol. 14(1) pp. 6
Mehlinger, Renee, 1991, Vol. 05(4) pp. 12
Meiselas, Karen D.
melatonin
for aluminum toxicity, 2003, Vol. 17(1) pp. 4
as antioxidant, 2001, Vol. 15(4) pp. 6
for attention, 1994, Vol. 08(3) pp. 1
in autism, 1991, Vol. 05(2) pp. 5; 1992, Vol. 06(2) pp. 2; 1993, Vol. 07(3) pp. 4; 1994, Vol. 08(3) pp. 6.
for behaviors, 1994, Vol. 08(3) pp. 12
and GABA, 1997, Vol. 11(4) pp. 7
in Rett's, 1988, Vol. 02(1) pp. 4
and seizures, 1997, Vol. 11(4) pp. 7; 2001, Vol. 15(4) pp. 6.
for tantrums, 1994, Vol. 08(3) pp. 12
for tardive dyskinesia, 2001, Vol. 15(4) pp. 6
and zinc, 2004, Vol. 18(2) pp. 5
Mellaril (thioridazine), 1991, Vol. 05(4) pp. 4; 2000, Vol. 14(4) pp. 4; 2003, Vol. 17(4) pp. 5.
Melnechuk, Ted, 1997, Vol. 11(3) pp. 3
Melnyk, Andrew, 1991, Vol. 05(3) pp. 5
memory
and conversation skills, 1990, Vol. 04(1) pp. 5
creatine for, 2003, Vol. 17(3) pp. 4
and mercury, 2000, Vol. 14(2) pp. 7; 2003, Vol. 17(2) pp. 7.
oxytocin's effects on, 2001, Vol. 15(1) pp. 4
perception and recognition in, 1996, Vol. 10(4) pp. 3
problems, 1987, Vol. 01(1) pp. 7
savant skills, 1987, Vol. 01(1) pp. 7; 1989, Vol. 03(1) pp. 1.
spatial memory, 2001, Vol. 15(1) pp. 6
Menage, P., 1993, Vol. 07(4) pp. 1
menopause in Fragile X carriers, 1998, Vol. 12(3) pp. 5; 1998, Vol. 12(4) pp. 7.
menstrual problems
amenorrhea and risperidone, 1999, Vol. 13(4) pp. 4; 2000, Vol. 14(3) pp. 4; 2001, Vol. 15(2) pp. 4.
Depo Provera for, 1999, Vol. 13(2) pp. 7
PMS, 1998, Vol. 12(3) pp. 6; 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(1) pp. 4.
menstrual training, 1990, Vol. 04(2) pp. 5; 1998, Vol. 12(1) pp. 7.
mental health care, 1991, Vol. 05(3) pp. 3
mental illness
Mental Retardation, department of (MA), 1995, Vol. 09(4) pp. 2; 1997, Vol. 11(3) pp. 5.
Mercer, Judith S., 2004, Vol. 18(1) pp. 6
Mercer, Kathleen Clark, 1993, Vol. 07(2) pp. 2
Merck (drug company), 2003, Vol. 17(3) pp. 7; 2004, Vol. 18(4) pp. 2.
mercuric chloride, 2004, Vol. 18(2) pp. 5
mercury, 1995, Vol. 09(1) pp. 7. See also thimerosol
and acrodynia, 2000, Vol. 14(4) pp. 3
amalgams of, 2000, Vol. 14(4) pp. 3
antibiotics and excretion, 2001, Vol. 15(4) pp. 7
and attention, 2003, Vol. 17(2) pp. 7
in baby products, 2000, Vol. 14(4) pp. 3
Brazil fishing communities' study, 2003, Vol. 17(2) pp. 7
chelation, 2003, Vol. 17(3) pp. 1; 2004, Vol. 18(3) pp. 3.
and cholinergic system, 2001, Vol. 15(3) pp. 7
in dental work, 2000, Vol. 14(4) pp. 3
detoxification, 2001, Vol. 15(1) pp. 1
EPA on, 2004, Vol. 18(1) pp. 4
excretion problems, 2003, Vol. 17(2) pp. 4; 2003, Vol. 17(3) pp. 1.
exposure suddenness, 2000, Vol. 14(3) pp. 2
FDA allowable exposures, 2003, Vol. 17(2) pp. 7
and fetal risk, 2004, Vol. 18(1) pp. 4
and glutathione, 2004, Vol. 18(4) pp. 1
and gut epithelia, 2001, Vol. 15(1) pp. 1
hair sample anomaly, 2002, Vol. 16(2) pp. 3
intravenous injection and oral ingestion compared, 2003, Vol. 17(4) pp. 2
and lupus, 2003, Vol. 17(3) pp. 5
"mercury-free" vaccines, 2004, Vol. 18(3) pp. 2
metal uptake problems, 2003, Vol. 17(2) pp. 4
metyl- and ethyl- mercury compared, 2000, Vol. 14(3) pp. 2; 2004, Vol. 18(4) pp. 2.
oral ingestion and intravenous injection compared, 2003, Vol. 17(4) pp. 2
and pica, 2001, Vol. 15(4) pp. 7
and pink disease, 2000, Vol. 14(4) pp. 3
toxicity symptoms and autism compared, 2000, Vol. 14(2) pp. 7; 2000, Vol. 14(3) pp. 1.
TTFD (thiamine tetrahydrofurfuryl disulfide) for removing, 2002, Vol. 16(3) pp. 4
vaccines without, 2001, Vol. 15(2) pp. 1
World Health Organization and UN Food and Agriculture Organization's report, 2003, Vol. 17(2) pp. 7
Mercury Detoxification Consensus Report, 2004, Vol. 18(3) pp. 3
Mercury Detoxification Protocol, 2001, Vol. 15(3) pp. 4
Mercury-Free Vaccine Act of 2004, 2004, Vol. 18(2) pp. 6
Mercury Policy Project, 2003, Vol. 17(2) pp. 7
meripidine (Demerol), 1999, Vol. 13(3) pp. 5; 2000, Vol. 14(4) pp. 7.
Merzenich, Michael, 1995, Vol. 09(4) pp. 2
Meserlian, Donald, 2001, Vol. 15(2) pp. 6
Mesibov, Gary
meta-analysis, 2004, Vol. 18(1) pp. 3
metabolic disorders
of adenosine deaminase, 2003, Vol. 17(4) pp. 4
amino-aciduria, 1987, Vol. 01(4) pp. 4; 1988, Vol. 02(4) pp. 7.
and antipsychotics, 2004, Vol. 18(2) pp. 2
in Asperger's, 1987, Vol. 01(4) pp. 4; 1988, Vol. 02(4) pp. 7.
and ATP, 1999, Vol. 13(3) pp. 4
and bipolar disorder, 2002, Vol. 16(1) pp. 2
in brain metabolism, 1987, Vol. 01(4) pp. 7; 1994, Vol. 08(1) pp. 4; 1999, Vol. 13(4) pp. 4.
of CD26, 2003, Vol. 17(4) pp. 4
celiac disease, 1993, Vol. 07(1) pp. 4
and clostridia, 1998, Vol. 12(4) pp. 6
coenzyme Q10, 1999, Vol. 13(4) pp. 4
creatine-phosphate, 1999, Vol. 13(3) pp. 4
developmental language disorder, 1987, Vol. 01(4) pp. 6
DHPPA metabolites, 1998, Vol. 12(4) pp. 6
of dipeptidylpeptidase (DPPIV), 2003, Vol. 17(4) pp. 4
of fatty acids, 2000, Vol. 14(4) pp. 6
and HVA (homovanillic acid), 1987, Vol. 01(4) pp. 4
hypermetabolic energy state, 1994, Vol. 08(1) pp. 4
lactic acidosis, 1987, Vol. 01(3) pp. 4
Landau-Kleffner as, 1991, Vol. 05(1) pp. 2
Lesch-Nyhan disorder, 1988, Vol. 02(3) pp. 3
metallothionein, 2001, Vol. 15(2) pp. 4
and NAD (nicotamide dinucleotide) production, 1999, Vol. 13(4) pp. 4
PET study on, 1988, Vol. 02(1) pp. 4; 1994, Vol. 08(4) pp. 4.
of phenols, 1994, Vol. 08(1) pp. 4; 2002, Vol. 16(1) pp. 7.
in purine metabolism, 1988, Vol. 02(3) pp. 3; 2001, Vol. 15(1) pp. 2.
pyridoxal phosphate deficiency and depression, 2004, Vol. 18(4) pp. 4
pyridoxine-dependent epilepsy, 2002, Vol. 16(2) pp. 2
retinal abnormalities, 1989, Vol. 03(3) pp. 4
in Rett's, 1987, Vol. 01(2) pp. 7; 1988, Vol. 02(1) pp. 4; 1989, Vol. 03(3) pp. 7; 1991, Vol. 05(2) pp. 4.
and serotonin, 1987, Vol. 01(4) pp. 67
of sulphates, 1994, Vol. 08(1) pp. 4
and tryptophan, 1999, Vol. 13(4) pp. 4
vitamin B6 for, 1988, Vol. 02(4) pp. 2
Metal Detox Medical Services, 1995, Vol. 09(4) pp. 7
metal poisoning. See also toxins, individual metals
aluminum, 2000, Vol. 14(4) pp. 3; 2001, Vol. 15(2) pp. 1; 2002, Vol. 16(3) pp. 2; 2003, Vol. 17(1) pp. 4.
antimony, 2002, Vol. 16(3) pp. 2
arsenic, 2002, Vol. 16(3) pp. 4
cadmium, 2002, Vol. 16(3) pp. 4
lead, 1988, Vol. 02(2) pp. 4; 1994, Vol. 08(1) pp. 5; 1995, Vol. 09(3) pp. 5; 1995, Vol. 09(4) pp. 7; 1998, Vol. 12(4) pp. 5; 2002, Vol. 16(3) pp. 4.
mercury (See mercury, thimerosol)
nickel, 2002, Vol. 16(3) pp. 4
metal uptake dysfunction, 2003, Vol. 17(2) pp. 4
metallothionein (MT) disorder, 2001, Vol. 15(2) pp. 4; 2002, Vol. 16(2) pp. 3.
metarepresentational skills, 1987, Vol. 01(4) pp. 1
methylation, 1991, Vol. 05(2) pp. 2; 2004, Vol. 18(1) pp. 1; 2004, Vol. 18(4) pp. 1.
methylcobalamin (B12), 2004, Vol. 18(1) pp. 1; 2004, Vol. 18(3) pp. 3; 2004, Vol. 18(4) pp. 1.
methylmalonic acid, 1998, Vol. 12(1) pp. 1
methylmercury, 2000, Vol. 14(3) pp. 2; 2003, Vol. 17(2) pp. 7; 2003, Vol. 17(4) pp. 1; 2004, Vol. 18(4) pp. 2.
methylphenidate (Ritalin)
and buspirone compared, 1994, Vol. 08(3) pp. 4
and cardiac arrest, 1996, Vol. 10(1) pp. 7
children's use of, 2004, Vol. 18(2) pp. 4
and depression in adults, 2004, Vol. 18(4) pp. 5
and fenfluramine compared, 1993, Vol. 07(4) pp. 4
and liver dysfunction, 2000, Vol. 14(1) pp. 2
and supplements compared, 1995, Vol. 09(1) pp. 7; 2003, Vol. 17(4) pp. 7.
for trichotillomania, 1991, Vol. 05(4) pp. 4
meuromuscular diseases, 1999, Vol. 13(3) pp. 4
Meyer, Dale, 1988, Vol. 02(2) pp. 3; 2000, Vol. 14(4) pp. 3.
Meyer, Gretchen, 1999, Vol. 13(1) pp. 6
Michigan, 2004, Vol. 18(4) pp. 3
microcomputers, 1988, Vol. 02(1) pp. 3
microglia, 2004, Vol. 18(4) pp. 12
midazolam (Versed), 1999, Vol. 13(3) pp. 5; 2000, Vol. 14(4) pp. 7.
Mikkelsen, Edwin J., 1990, Vol. 04(1) pp. 1
mild autism, 1988, Vol. 02(2) pp. 5; 1993, Vol. 07(1) pp. 5.
Miles, Judith, 2000, Vol. 14(1) pp. 4
Miles. S. W., 1987, Vol. 01(4) pp. 4; 1988, Vol. 02(4) pp. 7.
milk, 2003, Vol. 17(4) pp. 4
milk-free diet, 1992, Vol. 06(1) pp. 7; 1995, Vol. 09(4) pp. 6; 1996, Vol. 10(3) pp. 4; 1997, Vol. 11(1) pp. 6. See also casein-free diet
milk of magnesia, 2003, Vol. 17(1) pp. 7
Miller, Julie Ann, 1995, Vol. 09(2) pp. 4
Miller, Micheline, 1994, Vol. 08(1) pp. 6
Miller, N., 1991, Vol. 05(3) pp. 6
Miller, Neil Z., 1998, Vol. 12(1) pp. 3; 2002, Vol. 16(4) pp. 3.
Milner, C., 1998, Vol. 12(2) pp. 3
Milner, Yvonne, 1987, Vol. 01(1) pp. 5
Milstein, Janice, 1990, Vol. 04(1) pp. 5
Miltenberg, Raymond G., 1992, Vol. 06(3) pp. 5
MIND (Medical Investigation of Neurodevelopmental Disorders) Institute, 2000, Vol. 14(2) pp. 1; 2002, Vol. 16(3) pp. 1; 2003, Vol. 17(3) pp. 2.
Mind Reading (computer program), 2003, Vol. 17(2) pp. 5
Mindell, Jodi A., 1995, Vol. 09(3) pp. 1; 1995, Vol. 09(4) pp. 6.
mineral imbalances, 1997, Vol. 11(3) pp. 1
mineral oil, 2003, Vol. 17(3) pp. 5
mini double-blind trials, 1999, Vol. 13(3) pp. 3
Minnesota, 2004, Vol. 18(4) pp. 3
Minshew, Nancy J., 1994, Vol. 08(1) pp. 4; 2004, Vol. 18(4) pp. 5.
Miodownik, C., 2002, Vol. 16(3) pp. 4; 2003, Vol. 17(4) pp. 4.
mirror neuron deficits, 2001, Vol. 15(3) pp. 4
mirtrazapine (Remeron), 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(3) pp. 6.
MISS STIM, 1988, Vol. 02(4) pp. 2
Missouri, 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(4) pp. 3.
Mitchell, P., 2002, Vol. 16(3) pp. 5
Mitchell, Stella, 1997, Vol. 11(2) pp. 5
mitochondrial defects, 1991, Vol. 05(2) pp. 4; 1999, Vol. 13(4) pp. 4; 2004, Vol. 18(2) pp. 4.
mixed-handedness, 1987, Vol. 01(4) pp. 2
Miyamoto, A., 1999, Vol. 13(4) pp. 6
Miyashita, Teruko, 1989, Vol. 03(4) pp. 5
MMR vaccine. See measles-mumps-rubella vaccine
Modahl, Charlotte, 1992, Vol. 06(3) pp. 4; 1996, Vol. 10(3) pp. 2; 1997, Vol. 11(4) pp. 7.
Moebius mouth, 2004, Vol. 18(3) pp. 5
Moebius Syndrome, 1988, Vol. 02(1) pp. 2; 1989, Vol. 03(4) pp. 4.
Moglia-Johnson, Lisa, 2001, Vol. 15(1) pp. 6
Molliver, Derek, 1990, Vol. 04(2) pp. 4
Molliver, Mark, 1990, Vol. 04(2) pp. 4
Monihan, Maureen, 1992, Vol. 06(3) pp. 6
monoamines, 1988, Vol. 02(1) pp. 1
monoclonal antibodies, 1999, Vol. 13(1) pp. 5
monovalent vaccines, 2003, Vol. 17(3) pp. 7
Montagu, Ashley, 1987, Vol. 01(3) pp. 3
Montgomery, Scott, 2000, Vol. 14(4) pp. 1
mood disorders, 1999, Vol. 13(1) pp. 2 See also anxiety, bipolar disorder, depression
and Aspartame, 1997, Vol. 11(4) pp. 2
from Epstein-Barr infection, 2001, Vol. 15(1) pp. 4
in seizure patients, 2001, Vol. 15(2) pp. 7
supplements for, 1991, Vol. 05(2) pp. 7; 1992, Vol. 06(1) pp. 6; 1993, Vol. 07(1) pp. 7; 1994, Vol. 08(4) pp. 7; 2002, Vol. 16(4) pp. 4.
mood swings, 1998, Vol. 12(2) pp. 2; 1999, Vol. 13(1) pp. 5; 2001, Vol. 15(1) pp. 4; 2001, Vol. 15(4) pp. 5.
Moody, James A., 2004, Vol. 18(4) pp. 2
Mooney, Patricia, 1993, Vol. 07(3) pp. 6
Moore, D.W. York, 1993, Vol. 07(2) pp. 4
Moore, Monique, 2000, Vol. 14(4) pp. 5
Moore, S. J., 2000, Vol. 14(3) pp. 5
Moore, Tom, 1994, Vol. 08(4) pp. 7
"more effort" restraints, 2000, Vol. 14(2) pp. 5
Moreland, Aaron, 1994, Vol. 08(4) pp. 2
Morley, George Malcolm, 2004, Vol. 18(1) pp. 6
Morphett, Lurline, 1988, Vol. 02(3) pp. 7
Morrell, Frank, 1991, Vol. 05(1) pp. 2; 1996, Vol. 10(2) pp. 6; 1997, Vol. 11(3) pp. 4.
Morris, A., 2002, Vol. 16(1) pp. 6
Morris, D., 1990, Vol. 04(3) pp. 4
Morrow, J. D., 1990, Vol. 04(4) pp. 5
mortality. See also life expectancy
in aboriginal children, 1998, Vol. 12(1) pp. 3; 2000, Vol. 14(1) pp. 5; 2002, Vol. 16(4) pp. 3.
in community residential care, 1996, Vol. 10(3) pp. 7; 1996, Vol. 10(4) pp. 1; 1999, Vol. 13(4) pp. 1.
from drugs, 1994, Vol. 08(1) pp. 1; 1996, Vol. 10(1) pp. 7.
Mortenson, Mary, 1991, Vol. 05(1) pp. 4
Morton, L. L., 1988, Vol. 02(4) pp. 4
Mosholder, Andrew, 2004, Vol. 18(1) pp. 2; 2004, Vol. 18(3) pp. 2.
Moss, Mary, 1992, Vol. 06(3) pp. 3
motion perception, 1995, Vol. 09(4) pp. 5; 2003, Vol. 17(2) pp. 6.
motor cortex, 1993, Vol. 07(1) pp. 4
motor issues. See coordination
motor planning, 1997, Vol. 11(2) pp. 4
motor skills. See coordination
mouthguards, 1991, Vol. 05(3) pp. 5
movement disorders, 2000, Vol. 14(2) pp. 7; 2003, Vol. 17(1) pp. 6.
Movig, Kris L. L.
MRI studies, 1987, Vol. 01(1) pp. 1; 1988, Vol. 02(2) pp. 1; 1988, Vol. 02(4) pp. 1; 1989, Vol. 03(3) pp. 4; 1991, Vol. 05(2) pp. 4; 1991, Vol. 05(3) pp. 4; 2004, Vol. 18(2) pp. 4; 2004, Vol. 18(3) pp. 2.
MT disorder, 2001, Vol. 15(2) pp. 4; 2002, Vol. 16(2) pp. 3.
Mudford, Oliver C., 1989, Vol. 03(3) pp. 2; 1995, Vol. 09(1) pp. 6.
Muh, J.P., 1990, Vol. 04(1) pp. 7
Muir, Annette, 1992, Vol. 06(3) pp. 1
Mulick, James, 2003, Vol. 17(3) pp. 1
Mulinare, Joseph, 1989, Vol. 03(2) pp. 4
Muller, Norbert, 2000, Vol. 14(2) pp. 4
Muller-Vahl, K. R., 1998, Vol. 12(2) pp. 7; 2003, Vol. 17(1) pp. 4.
multi-channel sensory experiences, 1991, Vol. 05(4) pp. 7; 1997, Vol. 11(3) pp. 7.
multimodal cortex, 2001, Vol. 15(1) pp. 6
multiple complex developmental disorder, 1996, Vol. 10(2) pp. 4
multiple sclerosis, 2004, Vol. 18(4) pp. 7
multiple subpial transection, 1991, Vol. 05(1) pp. 2; 1995, Vol. 09(2) pp. 2; 1996, Vol. 10(2) pp. 1; 2002, Vol. 16(2) pp. 7.
mumps, 1998, Vol. 12(3) pp. 3
Munarriz, Ricardo, 2002, Vol. 16(4) pp. 67
Mundy, Peter, 1993, Vol. 07(1) pp. 6
Murai, T., 2002, Vol. 16(4) pp. 6
Murakami, James W., 1989, Vol. 03(3) pp. 4
Murdoch Center, 1995, Vol. 09(1) pp. 5
Muris, Peter, 1998, Vol. 12(4) pp. 6
Murphy, Anne, 1993, Vol. 07(4) pp. 6
Murray, Susan, 1993, Vol. 07(4) pp. 6
music, 1996, Vol. 10(1) pp. 5; 1998, Vol. 12(1) pp. 5.
musical abilities, 1989, Vol. 03(1) pp. 2
Mycoplasma pneumoniae, 2000, Vol. 14(2) pp. 4
myelin basic protein (MBP), 1993, Vol. 07(1) pp. 5; 2000, Vol. 14(4) pp. 1; 2004, Vol. 18(2) pp. 1; 2004, Vol. 18(4) pp. 4.
myelination
Myles, Brenda Smith, 1994, Vol. 08(2) pp. 5
myocarditis, 2002, Vol. 16(1) pp. 4
© copyright 2005, 2006 Autism Research Institute
|
|
